TOP TIERMARKET NEWSWIRE
News & sentiment

BICYCLE THERAPEUTICS ADR (BCYC) — News & AI sentiment

BICYCLE THERAPEUTICS ADR (BCYC) news roundup. 7 stories aggregated over the last 30 days. Average 30-day sentiment is 50.4/100. Recent insider activity (SEC Form 4, 90-day window): 0 purchases totalling $0 and 1 sales totalling $1K — net selling of $1K. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →
24h stories
0
7d stories
0
30d stories
7
avg sentiment 50.4/100
Insider net (90d)
$1K
0 buys · 1 sells
Congress (90d)
0
0 buys · 0 sells

BCYC news in the last 24 hours, 7 days, 30 days and 90 days

How much BCYC coverage the wire captured in each window, with the average AI sentiment across those stories. Counts are of stories that have cleared the 4-hour public delay.

Time windowBCYC storiesAvg AI sentimentRead
Last 24 hours0—no coverage
Last 7 days0—no coverage
Last 30 days750.4/100BCYC headlines →
Last 90 days1052.4/100BCYC headlines →

Latest stories on BCYC

Oct 30
Jefferies cuts Bicycle Therapeutics stock price target on trial timing
Investing.com Analyst Ratings34 · bearishanalyst
Oct 29
Oct 29
Oct 29
Oct 29
Oct 29
Oct 29
Sep 28
Sep 22
Aug 20
Aug 4
Jul 31
Jul 30
Jul 30
Jun 18
Jun 1
May 21
May 21
Open BCYC in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →